Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience

<b>Multiple</b> myeloma (MM) represents 1.8% of all new cancer cases in the U.S. While not curable, advances in treatment, including autologous stem cell transplant (ASCT) and maintenance therapy, have dramatically improved progression-free survival (PFS) and overall survival (OS). We pe...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Jordan Nunnelee, Francesca Cottini, Qiuhong Zhao, Muhammad Salman Faisal, Patrick Elder, Ashley Rosko, Naresh Bumma, Abdullah Khan, Srinivas Devarakonda, Don M. Benson, Yvonne Efebera, Nidhi Sharma
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2022-05-01
Reeks:Cancers
Onderwerpen:
multiple myeloma
novel agents
older
FISH
ASCT
Online toegang:https://www.mdpi.com/2072-6694/14/9/2277
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items